Retinal Vasculitis: Clinical Trials

1 trial for Retinal Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Retinal Vasculitis: new trials by email Literature Review of Retinal Vasculitis trials Research Report on Retinal Vasculitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)
Cyclosporin A, Interferon-alpha2a - Behcet's Disease, Panuveitis
Phase 3CompletedUniversity Hospital Tuebingen372004-11-012018-05-17

Narrower conditions

Behcet Syndrome (1)  ·  Panuveitis (1)  ·  Uveitis, Posterior (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Eye Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hereditary Autoinflammatory Diseases (1)  ·  Mouth Diseases (1)  ·  Retinal Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Stomatognathic Diseases (1)  ·  Uveal Diseases (1)  ·  Uveitis (1)  ·  Uveitis, Anterior (1)

Interventions

Cyclosporine (1)  ·  Interferon alpha-2 (1)

Sponsors

University Hospital Tuebingen (1)

Countries

Germany (1)

Top investigators

Ina Koetter, MD (1)